Edwards Lifesciences Revenue Growth Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 111  0.95  0.86%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Revenue Growth of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the growth in Revenues over the specified period.
Revenue Growth  10 Years Trend  
Decreasing
Stable
 Revenue Growth 
      Timeline 

Edwards Lifesciences Revenue Growth Over Time

2015-12-31  0.073529 
2016-12-31  0.073529 
2017-12-31  0.11 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  0.11
Geometric Mean  0.1
Coefficient Of Variation  43.73
Mean Deviation  0.038111
Median  0.11
Standard Deviation  0.048568
Sample Variance  0.002359
Range  0.17
R Value (0.31)
Mean Square Error  0.002338
R Squared  0.09885
Significance  0.32
Slope (0.004235)
Total Sum of Squares  0.025948

Currently Trending

BSX   
 NYQ 
Purchased over 200 shares of
few hours ago ago
Traded for 29.4
HCA   
 NYQ 
Purchased over 70 shares of
few hours ago ago
Traded for 0.0
INCY   
 NMS 
Purchased over 40 shares of
few hours ago ago
Traded for 0.0